Cargando…
Coronavirus-Specific T-Cells Can be Rapidly Expanded from Convalescent Donors for Potential Clinical Use
Autores principales: | Keller, Michael D., Harris, Katherine M., Conway, Susan, Durkee-Shock, Jessica, Jensen-Wachspress, Mariah, Kankate, Vaishnavi V, Lang, Haili, Lazarski, Christopher, Lee, Ping-Hsien, Chaudhry, Kajal, Webber, Kathleen, Datar, Anushree, Cohen, Jeffrey I., Jones, R. Brad, Cruz, Russell, Hoq, Fahmida, Bollard, Cath M., Hanley, Patrick J., Abraham, Alister, Stanojevic, Maja, Terpilowski, Madeline, Reynolds, Emily K, Stevenson, Eva, Val, Stephanie, Shancer, Zoe, Zhang, Nan, Geiger, Ashley, Liang, Hua, Dropulic, Lesia, Burbelo, Peter, Gangler, Krista |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Transplantation and Cellular. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847408/ http://dx.doi.org/10.1016/S2666-6367(21)00099-3 |
Ejemplares similares
-
SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein
por: Keller, Michael D., et al.
Publicado: (2020) -
T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1
por: Harris, Katherine M., et al.
Publicado: (2020) -
Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products
por: Durkee-Shock, Jessica, et al.
Publicado: (2022) -
Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency
por: Kinoshita, Hannah, et al.
Publicado: (2021) -
EPCT-15. THE REMIND TRIAL: MULTI-ANTIGEN TARGETED T CELLS FOR PEDIATRIC CNS TUMORS
por: Grant, Melanie, et al.
Publicado: (2020)